Company · CIK 0001434316 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
FATE THERAPEUTICS INC · FATE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 SForm 4 → | Aug 5, 4:03 pm EDT | Cindy TahlSee Remarks | 38,800 | $2.46 | $95,405 | 589,355 | −6.18% | |
| Aug 4, 2026 SForm 4 → | Aug 5, 4:01 pm EDT | Bahram ValamehrPresident and CEO, Director | 43,947 | $2.46 | $108,101 | 591,815 | −6.91% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2026 AForm 4 → | Jun 15, 5:16 pm EDT | Redmile Group, LLC +1Director, 10% Owner | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 5:15 pm EDT | Michael Stewart LeeDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:10 pm EDT | Yuan XuDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:09 pm EDT | Karin JoossDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:08 pm EDT | Robert S EpsteinDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:08 pm EDT | Shefali AgarwalDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:07 pm EDT | Matt AbernethyDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:06 pm EDT | William H RastetterDirector | 87,900 | — | — | 87,900 | — | |
| Jun 12, 2026 AForm 4 → | Jun 15, 4:05 pm EDT | Laura HamillDirector | 175,800 | — | — | 175,800 | — |